Current status of vitamin D signaling and its therapeutic applications.
暂无分享,去创建一个
[1] D. Viswanath,et al. Dietary Reference Intakes for Calcium and Vitamin D , 2012, Pediatrics.
[2] J. Pike,et al. Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand , 2011, Molecular and Cellular Endocrinology.
[3] V. Beneš,et al. Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy , 2011, Nucleic acids research.
[4] D. Moras,et al. Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. , 2011, MedChemComm.
[5] Dmitri I Svergun,et al. Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings , 2011, Nature Structural &Molecular Biology.
[6] D. Moras,et al. 1α,25(OH)2-3-Epi-Vitamin D3, a Natural Physiological Metabolite of Vitamin D3: Its Synthesis, Biological Activity and Crystal Structure with Its Receptor , 2011, PloS one.
[7] R. Heaney,et al. Why the IOM recommendations for vitamin D are deficient , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[8] Jun Zhang,et al. DNA binding alters coactivator interaction surfaces of the intact VDR–RXR complex , 2011, Nature Structural &Molecular Biology.
[9] Jussi Ryynänen,et al. Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1α,25-dihydroxyvitamin D3 , 2010, Nucleic Acids Res..
[10] Gavin Giovannoni,et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. , 2010, Genome research.
[11] A. Norman,et al. Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone. , 2010, Acta crystallographica. Section D, Biological crystallography.
[12] S. Heikkinen,et al. The down-regulation of the human MYC gene by the nuclear hormone 1alpha,25-dihydroxyvitamin D3 is associated with cycling of corepressors and histone deacetylases. , 2010, Journal of molecular biology.
[13] C. Carlberg,et al. Dynamics of nuclear receptor target gene regulation , 2010, Chromosoma.
[14] C. Mathieu,et al. Vitamin D: a pleiotropic hormone. , 2010, Kidney international.
[15] N. Ito,et al. 22S-Butyl-1α,24R-dihydroxyvitamin D3: Recovery of vitamin D receptor agonistic activity , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[16] R. Simpson,et al. Interaction between vitamin D receptor with caveolin-3 and regulation by 1,25-dihydroxyvitamin D3 in adult rat cardiomyocytes , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[17] D. Moras,et al. Crystal structure of hereditary vitamin D-resistant rickets—Associated mutant H305Q of vitamin D nuclear receptor bound to its natural ligand , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[18] J. Pike,et al. A Downstream Intergenic Cluster of Regulatory Enhancers Contributes to the Induction of CYP24A1 Expression by 1α,25-Dihydroxyvitamin D3* , 2010, The Journal of Biological Chemistry.
[19] D. Moras,et al. Structure-function relationships and crystal structures of the vitamin D receptor bound 2 alpha-methyl-(20S,23S)- and 2 alpha-methyl-(20S,23R)-epoxymethano-1 alpha,25-dihydroxyvitamin D3. , 2010, Journal of Medicinal Chemistry.
[20] Ty C. Voss,et al. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription , 2009, Nature Cell Biology.
[21] P. Farnham. Insights from genomic profiling of transcription factors , 2009, Nature Reviews Genetics.
[22] H. Stunnenberg,et al. ChIP‐Seq of ERα and RNA polymerase II defines genes differentially responding to ligands , 2009, The EMBO journal.
[23] D. S. Broomhead,et al. Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription , 2009, Science.
[24] Anna Saramäki,et al. Cyclical Chromatin Looping and Transcription Factor Association on the Regulatory Regions of the p21 (CDKN1A) Gene in Response to 1α,25-Dihydroxyvitamin D3*S⃞ , 2009, Journal of Biological Chemistry.
[25] D. Schübeler,et al. Genetics and epigenetics: stability and plasticity during cellular differentiation. , 2009, Trends in genetics : TIG.
[26] N. Ito,et al. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor. , 2009, Journal of medicinal chemistry.
[27] G. Hager,et al. Dynamic access of the glucocorticoid receptor to response elements in chromatin. , 2009, The international journal of biochemistry & cell biology.
[28] H. Stunnenberg,et al. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. , 2008, Genes & development.
[29] W. Hakamata,et al. Structure of the ligand-binding domain of rat VDR in complex with the nonsecosteroidal vitamin D3 analogue YR301. , 2008, Acta crystallographica. Section F, Structural biology and crystallization communications.
[30] D. Moras,et al. Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor. , 2008, Chemistry & biology.
[31] H. DeLuca,et al. Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism. , 2008, Journal of medicinal chemistry.
[32] H. DeLuca,et al. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure. , 2008, Bioorganic & medicinal chemistry.
[33] D. Moras,et al. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor. , 2008, Chemistry & biology.
[34] A. Zambrano,et al. Vitamin D-Dependent Recruitment of Corepressors to Vitamin D/Retinoid X Receptor Heterodimers , 2008, Molecular and Cellular Biology.
[35] J. Hoenderop,et al. Calcium and phosphate homeostasis: Concerted interplay of new regulators , 2008, Annals of medicine.
[36] Anna Saramäki,et al. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to trichostatin A and 1α,25-dihydroxyvitamin D3 , 2007, Nucleic acids research.
[37] D. Trump,et al. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.
[38] Stephen B. Thomas,et al. SOLAR ultraviolet radiation and vitamin D: a historical perspective. , 2007, American journal of public health.
[39] G. Hooiveld,et al. Exploration of PPAR functions by microarray technology--a paradigm for nutrigenomics. , 2007, Biochimica et biophysica acta.
[40] D. Steinhilber,et al. Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene. , 2007, Biochimica et biophysica acta.
[41] D. Moras,et al. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol. , 2007, Archives of biochemistry and biophysics.
[42] H. DeLuca,et al. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations. , 2007, Archives of biochemistry and biophysics.
[43] C. Carlberg,et al. Selective use of multiple vitamin D response elements underlies the 1 α,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene , 2007, Nucleic acids research.
[44] Anna Saramäki,et al. Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[45] D. Moras,et al. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: Remodelling the LBP with one side chain rotation , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[46] T. Archer,et al. Nuclear receptors and chromatin remodeling machinery , 2007, Molecular and Cellular Endocrinology.
[47] Steven Henikoff,et al. Spreading of silent chromatin: inaction at a distance , 2006, Nature Reviews Genetics.
[48] Clifford A. Meyer,et al. Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.
[49] Sungtae Kim,et al. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. , 2006, Molecular endocrinology.
[50] Sungtae Kim,et al. Activation of Receptor Activator of NF-κB Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range Enhancers , 2006, Molecular and Cellular Biology.
[51] D. Moras,et al. Probing a water channel near the A-ring of receptor-bound 1α,25-dihydroxyvitamin D3 with selected 2α-substituted analogues , 2006 .
[52] Sungtae Kim,et al. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. , 2006, Molecular endocrinology.
[53] Sungtae Kim,et al. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. , 2006, Molecular endocrinology.
[54] C. Carlberg,et al. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. , 2006, Current topics in medicinal chemistry.
[55] C. Carlberg,et al. Vitamin D Receptor Agonists Specifically Modulate the Volume of the Ligand-binding Pocket* , 2006, Journal of Biological Chemistry.
[56] George Reid,et al. Transcription in four dimensions: nuclear receptor‐directed initiation of gene expression , 2006, EMBO reports.
[57] John H. White,et al. Convergence of vitamin D and retinoic acid signalling at a common hormone response element , 2006, EMBO reports.
[58] C. Banwell,et al. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor , 2006, Nucleic acids research.
[59] John H. White,et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. , 2005, Molecular endocrinology.
[60] C. Carlberg,et al. Regulation of multiple insulin-like growth factor binding protein genes by 1α,25-dihydroxyvitamin D3 , 2005, Nucleic acids research.
[61] C. Carlberg,et al. Gene regulatory potential of nonsteroidal vitamin D receptor ligands. , 2005, Molecular endocrinology.
[62] C. Carlberg,et al. Structural Determinants of the Agonist-independent Association of Human Peroxisome Proliferator-activated Receptors with Coactivators* , 2005, Journal of Biological Chemistry.
[63] C. Carlberg,et al. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. , 2005, Journal of molecular biology.
[64] C. Carlberg,et al. The Human Peroxisome Proliferator-activated Receptor δ Gene is a Primary Target of 1α,25-Dihydroxyvitamin D3 and its Nuclear Receptor , 2005 .
[65] S. Gery,et al. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells. , 2005, Cancer research.
[66] D. Moras,et al. Superagonistic Action of 14-epi-Analogs of 1,25-Dihydroxyvitamin D Explained by Vitamin D Receptor-Coactivator Interaction , 2005, Molecular Pharmacology.
[67] C. Carlberg,et al. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter , 2005, Nucleic acids research.
[68] S. Kato,et al. Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo* , 2005, Journal of Biological Chemistry.
[69] Sungtae Kim,et al. 1,25‐Dihydroxyvitamin D3 Stimulates Cyclic Vitamin D Receptor/Retinoid X Receptor DNA‐Binding, Co‐activator Recruitment, and Histone Acetylation in Intact Osteoblasts , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[70] M. Holick. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.
[71] O. Sansom,et al. PPARδ status and Apc-mediated tumourigenesis in the mouse intestine , 2004, Oncogene.
[72] J. Brooks,et al. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[73] F. Khanim,et al. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells , 2004, Oncogene.
[74] C. Carlberg,et al. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling. , 2004, Chemistry & biology.
[75] J. Schwabe,et al. Mechanism of the nuclear receptor molecular switch. , 2004, Trends in biochemical sciences.
[76] Jeffrey B. Cheng,et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[77] J. Brooks,et al. Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays , 2004, The Prostate.
[78] P. Malloy,et al. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. , 2004, Molecular endocrinology.
[79] C. Mathieu,et al. Microarray analysis of 1α,25-dihydroxyvitamin D3-treated MC3T3-E1 cells , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[80] M. Serio,et al. Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. , 2004, European journal of endocrinology.
[81] G. Hager,et al. Dynamics of nuclear receptor movement and transcription. , 2004, Biochimica et biophysica acta.
[82] H. DeLuca,et al. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. , 2004, Biochemistry.
[83] B. De Moor,et al. The Effects of 1α,25‐Dihydroxyvitamin D3 on the Expression of DNA Replication Genes , 2003 .
[84] N. Raghavachari,et al. Vitamin D Growth Inhibition of Breast Cancer Cells: Gene Expression Patterns Assessed by cDNA Microarray , 2003, Breast Cancer Research and Treatment.
[85] Heike Brand,et al. Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter , 2003, Cell.
[86] S. Nicosia,et al. G2/M Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through the Induction of GADD45 via an Exonic Enhancer* , 2003, Journal of Biological Chemistry.
[87] C. Cordon-Cardo,et al. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. , 2003, Cancer research.
[88] A. Yoshida,et al. Dramatic enhancement of antagonistic activity on vitamin D receptor: a double functionalization of 1alpha-hydroxyvitamin D3 26,23-lactones. , 2003, Organic letters.
[89] C. Carlberg,et al. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor. , 2003, Molecular endocrinology.
[90] I. Azumaya,et al. Design and synthesis of potent vitamin D receptor antagonists with A-ring modifications: remarkable effects of 2alpha-methyl introduction on antagonistic activity. , 2003, Bioorganic & medicinal chemistry.
[91] M. Lambert,et al. Activation of nuclear receptors: a perspective from structural genomics. , 2003, Structure.
[92] P. N. MacDonald,et al. Vitamin D: more than a "bone-a-fide" hormone. , 2003, Molecular endocrinology.
[93] T. Shinki,et al. Vitamin D and bone , 2003, Journal of cellular biochemistry.
[94] J. Schwabe,et al. A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease , 2003, Nature Structural Biology.
[95] C. Carlberg. Molecular basis of the selective activity of vitamin D analogues , 2003, Journal of cellular biochemistry.
[96] Duane D. Miller,et al. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. , 2003, Molecular pharmacology.
[97] Alexander E. Kel,et al. TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..
[98] O. Jänne,et al. Involvement of Proteasome in the Dynamic Assembly of the Androgen Receptor Transcription Complex* , 2002, The Journal of Biological Chemistry.
[99] Swann Sl,et al. Rational design of vitamin D3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets. , 2002 .
[100] D. Sharma,et al. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[101] J. Collins,et al. Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D(3). , 2002, American journal of physiology. Cell physiology.
[102] R. Kingston,et al. Cooperation between Complexes that Regulate Chromatin Structure and Transcription , 2002, Cell.
[103] C. Carlberg,et al. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists. , 2002, Journal of molecular biology.
[104] S. Swann,et al. Rational design of vitamin D3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets. , 2002, Organic letters.
[105] R. Evans,et al. Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.
[106] C. Allis,et al. Translating the Histone Code , 2001, Science.
[107] John H. White,et al. Regulation of Gene Expression by 1α,25-Dihydroxyvitamin D3 and Its Analog EB1089 under Growth-Inhibitory Conditions in Squamous Carcinoma Cells , 2001 .
[108] C. Carlberg,et al. Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. , 2001, Frontiers in bioscience : a journal and virtual library.
[109] Á. Pascual,et al. Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.
[110] C. Carlberg,et al. Different molecular mechanisms of vitamin D(3) receptor antagonists. , 2001, Molecular pharmacology.
[111] D. Moras,et al. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[112] C. Carlberg,et al. Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases. , 2001, The Journal of investigative dermatology.
[113] C. Carlberg,et al. Interaction of Two Novel 14‐Epivitamin D3 Analogs with Vitamin D3 Receptor‐Retinoid X Receptor Heterodimers on Vitamin D3 Responsive Elements , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[114] C. Carlberg,et al. Gene regulatory potential of 1α,25‐dihydroxyvitamin D3 analogues with two side chains , 2001, Journal of cellular biochemistry. Supplement.
[115] Myles Brown,et al. Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.
[116] C. Carlberg,et al. Structure Activity Relationship of Carboxylic Ester Antagonists of the Vitamin D3 Receptor , 2000 .
[117] A. Norman,et al. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change. , 2000, Molecular endocrinology.
[118] K. Inouye,et al. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. , 2000, European journal of biochemistry.
[119] C. Carlberg,et al. VDR‐Alien: a novel, DNA‐selective vitamin D3 receptor‐corepressor partnership , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[120] H. Koeffler,et al. Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions. , 2000, Journal of medicinal chemistry.
[121] C. Carlberg,et al. Antagonistic Action of a 25-Carboxylic Ester Analogue of 1α,25-Dihydroxyvitamin D3 Is Mediated by a Lack of Ligand-induced Vitamin D Receptor Interaction with Coactivators* , 2000, The Journal of Biological Chemistry.
[122] C. Carlberg,et al. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists. , 2000, Molecular pharmacology.
[123] J. Chen,et al. The SRC family of nuclear receptor coactivators. , 2000, Gene.
[124] M. Galligan,et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. , 2000, Molecular endocrinology.
[125] C. Carlberg,et al. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. , 2000, Journal of molecular biology.
[126] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[127] D. Moras,et al. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. , 2000, Molecular cell.
[128] K. Ozono,et al. Analysis of the Molecular Mechanism for the Antagonistic Action of a Novel 1α,25-Dihydroxyvitamin D3 Analogue toward Vitamin D Receptor Function* , 1999, The Journal of Biological Chemistry.
[129] M. Lazar,et al. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors , 1999, Nature.
[130] A. Norman,et al. 1α,25‐Dihydroxyvitamin D3‐26,23‐lactone analogs antagonize differentiation of human leukemia cells (HL‐60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells) , 1999, FEBS letters.
[131] M. Groudine,et al. Looping versus linking: toward a model for long-distance gene activation. , 1999, Genes & development.
[132] M. Boehm,et al. Vitamin D3 mimics of , 1999 .
[133] A. Norman,et al. Antagonistic Action of Novel 1α,25-Dihydroxyvitamin D3-26,23-lactone Analogs on Differentiation of Human Leukemia Cells (HL-60) Induced by 1α,25-Dihydroxyvitamin D3 * , 1999, The Journal of Biological Chemistry.
[134] X. Wang,et al. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45 , 1999, Oncogene.
[135] L. Mere,et al. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3. , 1999, Chemistry & biology.
[136] Paul Tempst,et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex , 1999, Nature.
[137] J. Katzenellenbogen,et al. Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens. , 1999, Chemistry & biology.
[138] C. Glass,et al. Coactivator and corepressor complexes in nuclear receptor function. , 1999, Current opinion in genetics & development.
[139] P. Malloy,et al. The Vitamin D Receptor Gene Start Codon Polymorphism: A Functional Analysis of FokI Variants , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[140] H. DeLuca,et al. Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.
[141] T. Willson,et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.
[142] A. Razin,et al. CpG methylation, chromatin structure and gene silencing—a three‐way connection , 1998, The EMBO journal.
[143] R. Bouillon,et al. Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells , 1998, Molecular and Cellular Endocrinology.
[144] H. Gronemeyer,et al. The nuclear receptor ligand-binding domain: structure and function. , 1998, Current opinion in cell biology.
[145] R. Bouillon,et al. The Biological Activity of Nonsteroidal Vitamin D Hormone Analogs Lacking Both the C‐ and D‐Rings , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[146] C. Carlberg,et al. Gene regulation by vitamin D3. , 1998, Critical reviews in eukaryotic gene expression.
[147] Zbigniew Dauter,et al. Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.
[148] S. Kato,et al. 25-Hydroxyvitamin D3 1α-Hydroxylase and Vitamin D Synthesis , 1997 .
[149] David M. Heery,et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.
[150] A. Iavarone,et al. Transcriptional Activation of the Human p21WAF1/CIP1 Gene by Retinoic Acid Receptor , 1996, The Journal of Biological Chemistry.
[151] C. Carlberg,et al. High‐affinity nuclear receptor binding of 20‐epi analogues of 1,25‐dihydroxyvitamin D3 correlates well with gene activation , 1996, Journal of cellular biochemistry.
[152] E. Lees,et al. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. , 1996, Oncogene.
[153] A. Look,et al. Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors. , 1996, Genomics.
[154] S. Zanello,et al. Differing shapes of 1α,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: A status report , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[155] J. Jones,et al. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. , 1996, Cancer research.
[156] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[157] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[158] C. Carlberg,et al. Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling. , 1995, European journal of biochemistry.
[159] P. Sigler,et al. Structural determinants of nuclear receptor assembly on DNA direct repeats , 1995, Nature.
[160] R. Bouillon,et al. Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.
[161] C. Carlberg,et al. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation , 1995, Molecular and cellular biology.
[162] C. Carlberg,et al. Identification and characterization of a vitamin D3 response element of chicken carbonic anhydrase-II. , 1994, DNA and cell biology.
[163] Z. Su,et al. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. , 1994, Oncogene.
[164] C. Glass. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. , 1994, Endocrine reviews.
[165] C. Carlberg,et al. Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. , 1994, The Journal of biological chemistry.
[166] M. Becker‐André,et al. Interaction between retinoic acid and vitamin D signaling pathways. , 1993, The Journal of biological chemistry.
[167] S. Kliewer,et al. Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. , 1993, Science.
[168] C. Carlberg,et al. Two nuclear signalling pathways for vitamin D , 1993, Nature.
[169] K. Umesono,et al. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.
[170] K. Yamamoto,et al. Solution structure of the glucocorticoid receptor DNA-binding domain. , 1990, Science.
[171] J. Adams. Vitamin D metabolite-mediated hypercalcemia. , 1989, Endocrinology and metabolism clinics of North America.
[172] T. Menné,et al. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue. , 1989, Acta dermato-venereologica.
[173] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[174] M. Haussler,et al. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. , 1987, Science.
[175] L. Cavalli-Sforza,et al. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[176] H. Nowicki,et al. 1,25-Dihydroxycholecalciferol: Identification of the Proposed Active Form of Vitamin D3 in the Intestine , 1971, Science.
[177] Dudley H. Williams,et al. Identification of 1,25-Dihydroxycholecalciferol, a New Kidney Hormone controlling Calcium Metabolism , 1971, Nature.
[178] M. Haussler,et al. Chromosomal receptor for a vitamin D metabolite. , 2009, Proceedings of the National Academy of Sciences of the United States of America.